James Jakway

1.2k total citations
25 papers, 890 citations indexed

About

James Jakway is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, James Jakway has authored 25 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in James Jakway's work include Chemokine receptors and signaling (7 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). James Jakway is often cited by papers focused on Chemokine receptors and signaling (7 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). James Jakway collaborates with scholars based in United States. James Jakway's co-authors include Anthony DeFranco, A L DeFranco, Michael R. Gold, David W. Talmage, John T. Kung, Ethan M. Shevach, Beverly E. Barton, Marvín I. Siegel, Robert I. Mishell and Hongchen Qiu and has published in prestigious journals such as Science, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

James Jakway

25 papers receiving 824 citations

Peers

James Jakway
Julia M. Ayala United States
Richard W. Leu United States
Katsuji Sugie Japan
Claire Leveillé Canada
Victor Umansky Germany
Harald Dinter United States
J C Salomon France
Boris Tchernychev United States
Victoria L. Cohan United States
Katherine A. Felts United States
Julia M. Ayala United States
James Jakway
Citations per year, relative to James Jakway James Jakway (= 1×) peers Julia M. Ayala

Countries citing papers authored by James Jakway

Since Specialization
Citations

This map shows the geographic impact of James Jakway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Jakway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Jakway more than expected).

Fields of papers citing papers by James Jakway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Jakway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Jakway. The network helps show where James Jakway may publish in the future.

Co-authorship network of co-authors of James Jakway

This figure shows the co-authorship network connecting the top 25 collaborators of James Jakway. A scholar is included among the top collaborators of James Jakway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Jakway. James Jakway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goedken, Eric R., Viswanath Devanarayan, Christopher M. Harris, et al.. (2012). Minimum Significant Ratio of Selectivity Ratios (MSRSR) and Confidence in Ratio of Selectivity Ratios (CRSR): Quantitative Measures for Selectivity Ratios Obtained by Screening Assays. SLAS DISCOVERY. 17(7). 857–867. 10 indexed citations
2.
Taveras, Arthur G., Younong Yu, Junying Zheng, et al.. (2007). 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(1). 228–231. 16 indexed citations
3.
Gonsiorek, Waldemar, Xuedong Fan, David Hesk, et al.. (2007). Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist. Journal of Pharmacology and Experimental Therapeutics. 322(2). 477–485. 101 indexed citations
4.
Chao, Jianhua, Arthur G. Taveras, Jianping Chao, et al.. (2007). C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(13). 3778–3783. 38 indexed citations
5.
Ting, Pauline C., Shelby P. Umland, Robert Aslanian, et al.. (2005). The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: Antagonists versus agonists. Bioorganic & Medicinal Chemistry Letters. 15(12). 3020–3023. 15 indexed citations
6.
Ting, Pauline C., Jie Wu, Shelby P. Umland, et al.. (2005). The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 15(5). 1375–1378. 24 indexed citations
7.
Corboz, Michel R., Charles A. Rizzo, Maria A. Rivelli, et al.. (2003). Pharmacological characterization of α2‐adrenoceptor‐mediated responses in pig nasal mucosa. Autonomic and Autacoid Pharmacology. 23(4). 208–219. 19 indexed citations
8.
Zou, Jun, Simon Young, Feng Zhu, et al.. (2002). Identification of Differentially Expressed Genes in a Monkey Model of Allergic Asthma by Microarray Technology. CHEST Journal. 121(3). 26S–27S. 12 indexed citations
9.
Wan, Yuntao, James Jakway, Hongchen Qiu, et al.. (2002). Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPγS binding. European Journal of Pharmacology. 456(1-3). 1–10. 23 indexed citations
10.
Rizzo, Charles A., Michel R. Corboz, Shelby P. Umland, et al.. (2001). Postjunctional α2C-adrenoceptor contractility in human saphenous vein. European Journal of Pharmacology. 413(2-3). 263–269. 12 indexed citations
11.
Umland, Shelby P., Yuntao Wan, Himanshu Shah, et al.. (2000). Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells. Journal of Leukocyte Biology. 67(3). 441–447. 20 indexed citations
12.
Umland, Shelby P., Himanshu Shah, James Jakway, et al.. (1999). Effects of Cyclosporin A and Dinactin on T-Cell Proliferation, Interleukin-5 Production, and Murine Pulmonary Inflammation. American Journal of Respiratory Cell and Molecular Biology. 20(3). 481–492. 18 indexed citations
13.
Barton, Beverly E., et al.. (1991). Cytokine Inhibition by A Novel Steroid, Mometasone Furoate. Immunopharmacology and Immunotoxicology. 13(3). 251–261. 63 indexed citations
14.
Gold, Michael R., James Jakway, & A L DeFranco. (1987). Involvement of a guanine-nucleotide-binding component in membrane IgM-stimulated phosphoinositide breakdown.. The Journal of Immunology. 139(11). 3604–3613. 72 indexed citations
15.
Jakway, James, William R. Usinger, Michael R. Gold, Robert I. Mishell, & A L DeFranco. (1986). Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products.. The Journal of Immunology. 137(7). 2225–2231. 66 indexed citations
16.
Jakway, James & Anthony DeFranco. (1986). Pertussis Toxin Inhibition of B Cell and Macrophage Responses to Bacterial Lipopolysaccharide. Science. 234(4777). 743–746. 116 indexed citations
17.
Jakway, James & Ethan M. Shevach. (1984). Mycoplasma contamination: a hazard of screening hybridoma supernatants for inhibition of [3H]thymidine incorporation. Journal of Immunological Methods. 67(2). 337–345. 7 indexed citations
18.
Malek, Thomas R., et al.. (1984). The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro.. The Journal of Immunology. 133(4). 1976–1982. 58 indexed citations
19.
Kung, John T., et al.. (1977). Suppression of in vitro cytotoxic response by macrophages due to induced arginase.. The Journal of Experimental Medicine. 146(3). 665–672. 157 indexed citations
20.
Jakway, James, David W. Thomas, & David W. Talmage. (1975). Activation of T-Lymphocye Helper Function by Brief Exposure to Antigen-Pulsed Macrophages. Experimental Biology and Medicine. 150(3). 791–795. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia M. Ayala Breakdown of academic impact, for papers by Richard W. Leu Breakdown of academic impact, for papers by Katsuji Sugie Breakdown of academic impact, for papers by Claire Leveillé Breakdown of academic impact, for papers by Victor Umansky Breakdown of academic impact, for papers by Harald Dinter Breakdown of academic impact, for papers by J C Salomon Breakdown of academic impact, for papers by Boris Tchernychev Breakdown of academic impact, for papers by Victoria L. Cohan Breakdown of academic impact, for papers by Katherine A. Felts
Rankless by CCL
2026